Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) (NCT07711691)
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+): A Multi-Site Pilot Randomized Controlled Trial
🩺 Plain-English Summary (8th-Grade Level)
Lung cancer screening (LCS) with low-dose computed tomography (LDCT) can reduce the risk of dying from lung cancer, but many people who are eligible for screening do not receive it. The purpose of the Empower LCS/Call+ study is to evaluate new strategies to improve lung cancer screening among adults who are eligible for screening based on current U.S. Preventive Services Task Force (USPSTF) guidelines. This pilot randomized controlled trial will enroll approximately 80 participants from UC Irvine Health and Emory Healthcare. Participants will be randomly assigned to receive either enhanced usual care or the Empower LCS/Call+ intervention. The intervention includes educational materials, reminders for patients and primary care providers, and information about financial and community resources when appropriate. Participants who do not complete lung cancer screening after the initial intervention may receive additional telephone-based navigation through the Call+ program to help identify and address barriers to screening and help with scheduling. Participants will complete a baseline survey and follow-up surveys at 4 and 8 months, and researchers will review electronic health record information to determine whether lung cancer screening was discussed, ordered, and completed. Some participants will also be invited to complete a one-time interview about their experiences with the study. The results of this study will help determine the feasibility, acceptability, and preliminary effectiveness of the Empower LCS/Call+ intervention and will inform future efforts to improve equitable access to lung cancer screening.
Who can join: Review the eligibility criteria below.
Location: UCI Health Family Health Center - Anaheim — Anaheim, California
Age range: 50 Years to 80 Years
🧪 Interventions in This Study
- Empower LCS (BEHAVIORAL)
- Call+ Telephone Navigation (BEHAVIORAL)
- Usual Care (OTHER)
- Education (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (57 Sites)
Showing the first 25 of 57 sites.
- UCI Health Family Health Center - Anaheim — Anaheim, California
- UCI Health - Costa Mesa — Costa Mesa, California
- CHAO Family Comprehensive Cancer Center- Irvine — Irvine, California
- UCI Health Gottschalk Medical Plaza — Irvine, California
- UCI Health - Laguna Hills — Laguna Hills, California
- UCI Health - Newport Beach MacArthur — Newport Beach, California
- Primary Care & Internal Medicine Services — Orange, California
- UCI Chao Family Comprehensive Cancer Center — Orange, California
- UCI Health SeniorHealth Center -Pavillion 4 — Orange, California
- UCI Medical Center, Pavilion 3 — Orange, California
- UCI Health Family Health Center - Santa Ana — Santa Ana, California
- UCI Health - Tustin — Tustin, California
- UCI Health - Yorba Linda — Yorba Linda, California
- Emory at Avalon - Primary Care — Alpharetta, Georgia
- Emory Clinic at Old Fourth Ward — Atlanta, Georgia
- Emory Clinic at Midtown — Atlanta, Georgia
- Emory at Peachtree Hills - Primary Care — Atlanta, Georgia
- Emory Clinic at 1365 Clifton Road - Primary Care — Atlanta, Georgia
- Emory Clinic at 1525 Clifton Road - Primary Care — Atlanta, Georgia
- Emory at Toco Hills - Primary Care — Atlanta, Georgia
- Emory Gastroenterology — Atlanta, Georgia
- Emory at Northlake - Primary Care — Atlanta, Georgia
- Emory at Buford - Primary Care — Buford, Georgia
- Emory at Decatur - Primary Care (Irvin Court) — Decatur, Georgia
- Emory at Decatur - Primary Care (Scott Boulevard) — Decatur, Georgia
📞 Contact the Study Coordinator
Phone: (714) 456-3610
Email: gsadigh@hs.uci.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer Screening
- Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM) — Bogotá,
- LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI) — Chicago, Illinois
- Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation — Ashland, Kentucky
- A Study of Lung Cancer Screening in People With Unexplained Weight Loss — Basking Ridge, New Jersey
- Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans — New Orleans, Louisiana
Explore by condition: All Lung Cancer Screening clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.